Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety Disorders
Keywords: AMPA potentiator; Antidepressant; CRF1 antagonist; GABAB antagonist; GABAB positive modulator; MC4 anatgonist; MCH1R antagonist; NK1 antagonist; NK2 antagonist; V1a antagonist; V1b antagonist; anxiolytic; group I mGluR antagonist; group II mGluR agonist; group II mGluR antagonist
Document Type: Research Article
Affiliations: Medicinal Pharmacology Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama 331-9530, Japan;
Publication date: 2006-01-01
- Recent Patents on CNS Drug Discovery publishes review articles on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery.